ADF-STEM imaging of nascent phases and extended disorder within the Mo–V–Nb–Te–O catalyst system by Vogt, T, Blom, D, Jones, L, Buttrey, D

Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. by Blom, D, Koren, M, Roth, E, Monsalvo, M, Djedjos, C, Nelson, P, Elliott, M, Wasserman, S, Ballantyne, C, Holman, R

Effect of the proprotein convertase subtilisin/kexin type 9 inhibitor evolocumab on glycemia, body weight, and new-onset diabetes mellitus by Sattar, N, Toth, P, Blom, D, Koren, M, Soran, H, Uhart, M, Elliott, M, Cyrille, M, Somaratne, R, Preiss, D